Patents by Inventor Raimo Virtanen

Raimo Virtanen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of dependence and dependence related withdrawal symptoms
    Publication number: 20060058364
    Abstract: A method for treatment of dependence and dependence related withdrawal symptoms caused by the discontinuation of subacute or chronic use of psychostimulant agents, to ease a patient's withdrawal from the psychostimulants with an alpha2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof.
    Type: Application
    Filed: March 28, 2003
    Publication date: March 16, 2006
    Inventors: Antti Haapalinna, Timo Viitamaa, Raimo Virtanen
  • Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
    Patent number: 6495584
    Abstract: The present invention relates to a method for obtaining analgesia by administering 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enetiomer or pharmaceutically acceptable ester or salt thereof to a mammal intraspinally, 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enantiomer or a pharmaceutically acceptable ester or salt thereof can be administered intraspinally to a mammal obtaining analgesia without side-effects, such as sedation. The present invention also relates to a method for using the drug as an adjunct to anaesthesia by administering it intraspinally.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: December 17, 2002
    Assignee: Orion Corporation
    Inventors: Antti Haapalinna, Jyrki Lehtimäki, Tiina Leino, Timo Viitamaa, Raimo Virtanen
  • Treatment method
    Publication number: 20020115704
    Abstract: A method for the treatment of female sexual dysfunction and enhancement of normal sexual function in females with an alpha2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof.
    Type: Application
    Filed: December 14, 2001
    Publication date: August 22, 2002
    Inventors: Ilkka Linnankoski, Antti Pertovaara, Antti Haapalinna, Raimo Virtanen
  • Transmucosal formulations of levosimendan
    Patent number: 6399610
    Abstract: A method of administering transmucosally, particularly to oral or nasal mucosa, levosimendan or a pharmaceutically acceptable salt thereof to a patient. The method comprises contacting an intact mucous membrane with a source of levosimendan, and maintaining said source with said mucous membrane for a sufficient time period to deliver levosimendan to the patient. Transmucosal preparations of levosimendan are also described. Levosimendan is useful in the treatment of heart failure.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: June 4, 2002
    Assignee: Orion Corporation
    Inventors: Kauko Kurkela, Martti Marvola, Ilkka Larma, Raimo Virtanen, Marianne Karlsson
  • Imidazole derivatives
    Patent number: 6388090
    Abstract: An imidazole derivative of formula (I) or a pharmaceutically acceptable salt or derivative thereof. The compounds of formula I exhibit affinity for alpha2 adrenoceptors.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: May 14, 2002
    Assignee: Orion Corporation
    Inventors: Paavo Huhtala, Arto Karjalainen, Antti Haapalinna, Jyrki Lehtimäki, Arja Karjalainen, Raimo Virtanen
  • Polycyclic indanylimidazoles with alpha2 adrenergic activity
    Patent number: 6362211
    Abstract: A compound of formula I wherein R1 to R3, —A—, m and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha2 adrenergic agent.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: March 26, 2002
    Assignee: Orion Corporation
    Inventors: Jari Ratilainen, Paavo Huhtala, Arto Karjalainen, Arja Karjalainen, Antti Haapalinna, Raimo Virtanen, Jyrki Lehtimäki
  • New polycyclic indanylimidazoles with alpha2 adrenergic activity
    Publication number: 20020013356
    Abstract: A compound of formula I 1
    Type: Application
    Filed: May 7, 2001
    Publication date: January 31, 2002
    Inventors: Jari Ratilainen, Paavo Huhtala, Arto Karjalainen, Arja Karjalainen, Antti Haapalinna, Raimo Virtanen, Jyrki Lehtimaki
  • Imidazole derivatives
    Publication number: 20010056109
    Abstract: An imidazole derivative of formula (I) 1
    Type: Application
    Filed: January 12, 2001
    Publication date: December 27, 2001
    Inventors: Paavo Huhtala, Arto Karjalainen, Antti Haapalinna, Jyrki Lehtimaki, Arja Karjalainen, Raimo Virtanen
  • Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
    Patent number: 5541211
    Abstract: The present invention is in the art of eliciting a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic neurotransmission male sexual activity response in penile erection. The improvement involves a more rapid onset of action and improved effect than that of yohimbine, consisting essentially of the step of administering the compound atipamezole or a pharmaceutically acceptable acid addition salt thereof to a male in need thereof. Atipamezole or pharmaceutically acceptable acid salt thereof may be administered perorally, intravenously, intramuscularly, transmucosally or transdermally.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: July 30, 1996
    Assignee: Orion-yhtyma Oy
    Inventors: Antti Pertovaara, Ilkka Linnankoski, Raimo Virtanen
  • Compositions and their use in lowering intraocular pressure
    Patent number: 5304569
    Abstract: Compounds of formula: ##STR1## where X is --CH.sub.2 --, --CH(CH.sub.3)--, --CHR.sub.3 --CH.sub.2 -- or --CR.sub.3 .dbd.CH-- and R.sub.1, R.sub.2 and R.sub.3, which can be the same or different, are each H or CH.sub.3 or a stereoisomer or pharmaceutically acceptable salt thereof, and pharmaceutical compositions containing them, are useful for lowering intraocular pressure in a mammal, e.g. in the treatment of glaucoma.
    Type: Grant
    Filed: October 31, 1990
    Date of Patent: April 19, 1994
    Assignee: Orion-yhtyma Oy
    Inventors: Risto Lammintausta, Arto Karjalainen, Ewen MacDonald, Arto Urtti, Raimo Virtanen, Thomas Yorio
  • Anxiolytic composition
    Patent number: 4783477
    Abstract: Medetomidine is useful in the treatment of anxiety disorders.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: November 8, 1988
    Assignee: Farmos-Yhtyma Oy
    Inventors: Risto Lammintausta, Raimo Virtanen